Showing results (491-500 of 6,990) with videos related to
Sort By:
Pageof 699
Cancer Science|December 8, 2022
Phase 1 trial of zolbetuximab in Japanese patients with CLDN18.2+ gastric or gastroesophageal junction adenocarcinomaKohei Shitara, Akihito Kawazoe, Akihiro Hirakawa, et al.Cancer Science|December 8, 2022
Characterization of myeloid signature genes for predicting prognosis and immune landscape in Ewing sarcomaZhao Zhang, Yubo Shi, Zhijie Zhu, et al.Cancer Science|July 6, 2022
Pembrolizumab plus chemotherapy in Japanese patients with persistent, recurrent or metastatic cervical cancer: Results from KEYNOTE-826Shin Nishio, Kan Yonemori, Tomoka Usami, et al.Cancer Science|January 5, 2023
Downregulated mitochondrial transcription factor A enhances mycoplasma infection to promote the metastasis of hepatocellular carcinomaYinping Wang, Gang Wang, Xin Hong, et al.Cancer Science|January 5, 2023
Clinical utility of Todai OncoPanel in the setting of approved comprehensive cancer genomic profiling tests in JapanHidenori Kage, Aya Shinozaki-Ushiku, Kazunaga Ishigaki, et al.Cancer Science|January 16, 2023
CircLASP1 silence strengthens the therapeutic effects of MK-2206 on nasopharyngeal cancer through upregulating miR-625Li-Na Xu, Si-Le Liu, Yang Yang, et al.Cancer Science|December 26, 2022
Single-cell next-generation sequencing of circulating tumor cells in patients with neuroblastomaMasato Kojima, Takanori Harada, Takahiro Fukazawa, et al.Cancer Science|January 10, 2023
Frizzled-7-targeting antibody (SHH002-hu1) potently suppresses non-small-cell lung cancer via Wnt/β-catenin signalingKanghua Li, Shuyang Mao, Xingxing Li, et al.Cancer Science|January 24, 2023
Crizotinib-based proteolysis targeting chimera suppresses gastric cancer by promoting MET degradationJin-Jiao Chen, Jin-Mei Jin, Wen-Jie Gu, et al.Cancer Science|January 24, 2023
Boris knockout eliminates AOM/DSS-induced in situ colorectal cancer by suppressing DNA damage repair and inflammationBo-Wen Zuo, Wan-Xin Yao, Meng-Die Fang, et al.Pageof 699